Data updated as of January 23, 2021
The largest vaccination campaign in history has begun. The immunization process against Covid-19, which began in early December in the United States, United Kingdom, Russia and China, is underway throughout Europe and in most of the richest countries.
Spain started on December 27 the administration of the 4.5 million doses of Pfizer and BioNTech, which has also been reinforced with inoculated doses of Moderna’s vaccine. With both drugs, immunization is proposed in the first phase 2.3 million people, since Pfizer’s vaccine is a double dose: it requires two pricks 21 days apart. The first people to receive the vaccine in Spain are the elderly residing in nursing homes (which account for around half of the deaths from Covid-19), first-line health personnel and large dependents.
The following table shows the status of the vaccination process in Spain in each autonomous community. To date, virtually all the vaccines administered are from Pfizer. The number of doses administered, the percentage of those received in each autonomous community, the number of injected doses per inhabitant and the registered date of the last dose administered are shown. It must be taken into account that the doses per inhabitant do not represent the percentage of the immunized population since two injections are necessary.
From flattening to accelerating the curve
When the pandemic began, there was a main objective for all the countries of the world: to flatten the contagion curve. With the advent of the vaccine, the goal is to accelerate the vaccination curve to immunize millions of people in record time – a logistical and medical challenge never before done on a global scale.
In the case of Spain, the following graph shows the per capita dose curves that must be accelerated in the coming months. This comparison is useful to see if the speed of vaccination increases in each autonomous community (and in Spain in general) but it is less useful to make comparisons between regions since each one can maintain a different vaccination strategy. For example, the autonomous communities that have more residents among the target groups of the first phase (residences and health care) will have received more doses per inhabitant and, in addition, some regions are saving the booster vial to administer it when it is time for the second phase. dose.
The road to immunity in the world
Millions of people in a small number of countries around the world have already received at least one dose of some vaccine against Covid-19. The campaign began in many countries in December with emergency authorizations, in some cases using experimental drugs, and which has accelerated in recent weeks with the authorizations of several vaccines in the European Union.
The following map shows the countries that have administered the most doses per 100 inhabitants worldwide. Only figures for countries that have published data are shown, based on data collected by the portal Our World in Data.
The vaccination gap between rich and poor countries is beginning to show in the figures. So far, the majority of doses administered worldwide are concentrated in the Northern Hemisphere: virtually all of Europe has started vaccinating, along with the United States, Canada, and much of the Middle East. Indeed, Israel leads the vaccination campaign around the world with 50,000 daily doses which is explained by the digitization of the health system, the distribution of doses to avoid waste and centralization.
The difference between Israel’s vaccination curve and that of the rest of the countries is wide. Although the size and population of each country must also be taken into account to make comparisons: it is not the same to vaccinate 8 million people who live concentrated in 22,000 square kilometers than to vaccinate 47 million people who live in 500,000 square kilometers Of surface. To date, Pfizer’s vaccine is the most widespread among most countries, including Europe and the United States, with the exception of China and Russia, which are using their own drugs.
The economic gap becomes more visible when the doses administered are grouped by regions of the world. The vaccination process has barely begun in Latin America and Africa, compared to the countries with the highest per capita income, which accounted for most of the doses purchased before the vaccines were approved.